|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 43, 2196-2204, December 2002
Copyright © 2002 by Lipid Research, Inc.
Methods |
-tocopherol derivative as a prodrug for d-
-tocopherol and a two-step prodrug for S-
-CEHC




* Faculty of Pharmaceutical Sciences, Fukuoka University, Nanakuma, Johnan-ku, Fukuoka 814-0180, Japan
Laboratory of Bio-Analytical Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
1 To whom correspondence should be addressed. e-mail: jtakata{at}fukuoka-u.ac.jp
d-
-Tocopherol (
-Toc) and its major metabolite, 2, 7, 8-trimethyl-2S-(ß-carboxyethyl)-6-hydroxychroman (S-
-CEHC), are currently receiving attention concerning their unique pharmacological activities. In order to achieve the efficient delivery of
-Toc and S-
-CEHC in vivo, we synthesized d-
-tocopheryl N,N-dimethylglycinate hydrochloride (
-TDMG) as a water-soluble prodrug of
-Toc and a two-step prodrug of S-
-CEHC.
-TDMG is a solid (mp 161163°C) and is quite soluble in water over 50 mM. The hydrolysis of
-TDMG was effectively catalyzed by esterases in rat and human liver microsomes. The disposition of
-TDMG after iv administration in rats was compared with that of
-Toc solubilized with the surfactant, polyoxyethylene hydrogenated castor oil. The plasma and liver levels of
-Toc rapidly increased after the iv administration of the
-TDMG. The liver availability of
-Toc after the administration of
-TDMG was two times higher than that of the
-Toc administration. The relative systemic availability of S-
-CEHC after the
-TDMG administration was an equivalent value (102%), and the mean residence time of S-
-CEHC was eight times longer than the racemic
-CEHC administration.
Based on these results,
-TDMG was identified as the most promising water-soluble prodrug of
-Toc and the two-step prodrug of S-
-CEHC.
Abbreviations: AUC, area under the concentration-time curve; DBD-PZ, 4-N,N-dimethylaminosulfonyl-7-piperazino-2,1,3-benzoxadiazole; FD-MS, field desorption mass spectrometry; HCO-60, polyoxyethylene hydrogenated castor oil; 1H-NMR, proton nuclear magnetic resonance spectrometry;
-Toc, d-
-tocopherol;
-TDMG, d-
-tocopheryl N,N-dimethylglycinate hydrochloride; MRT, mean residence time; R-
-CEHC, 2,7,8-trimethyl-2R-(ß-carboxyethyl)-6-hydroxychroman; S-
-CEHC, 2,7,8-trimethyl-2S-(ß-carboxyethyl)-6-hydroxychroman; TFA, trifluoroacetic acid
Supplementary key words water-soluble prodrug drug delivery d-
-tocopherol two-step prodrug
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
N. Akaho, J. Takata, T. Fukushima, K. Matsunaga, A. Hattori, R. Hidaka, K. Fukui, M. Yoshida, T. Fujioka, Y. Karube, et al. Preparation and In Vivo Evaluation of a Water-Soluble Prodrug for 2R-{gamma}-Tocotrienol and as a Two-Step Prodrug for 2,7,8-Trimethyl-2S-({beta}-carboxyethyl)-6-hydroxychroman (S-{gamma}-CEHC) in Rat Drug Metab. Dispos., September 1, 2007; 35(9): 1502 - 1510. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |